肺肿瘤核素显像的临床应用进展

Clinical advance in radionuclide imaging of pulmonary cancer

  • 摘要: 核素显像在肺癌的诊断、分期、治疗后复发转移的监测、疗效和预后的判断等方面展示了重要的临床价值,日益受到临床的重视。对临床较为常用的67Ga、201Tl、99Tcm18F等放射性核素及其标记化合物的显像原理、临床应用、优缺点及进展情况进行介绍,并重点介绍了99Tcm甲氧基异丁基异腈(99Tcm-MIBI)、99Tcm-HL91、18F-氟脱氧葡萄糖(18F-FDG)肺肿瘤核素显像的l临床应用进展。

     

    Abstract: Radionuclide imaging of pulmonary cancer develops very rapidly in recent years.Its important value on the diagnosis, staging, monitoring recur and metastasis after treatment, and judging the curative effect and prognosis has been demonstrated.Clinicians pay more attention to it than before.This present article introduces the imaging principle, clinical use, good and bad points, progress situation of 67Ga, 201Tl, 99Tcm, 18F and their labelled compounds, which are more commonly used in clinical.And introduces the clinical progress of radionuclide imaging of pulmonary neoplasm concerning 99Tcm-sestamibi (99Tcm-MIBI),99Tcm-HL91and 18F-fluorodeoxyglucose (ISF-FDG) with emphasis.

     

/

返回文章
返回